Onyx Acquires Proteolix
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 10 (Table of Contents)
Published: 16 Oct-2009
DOI: 10.3833/pdr.v2009.i10.1259 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Onyx Pharmaceuticals acquired California-based Proteolix and its lead candidate, carfilzomib, in a deal valued at up to US$851 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS